First Identification of the New Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant (B.1.1.529) in Italy

Abstract We identified the first case in Italy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 variant, using whole-genome sequencing in an Italian subject traveling from Mozambique. Specific mutation profiles deserve further investigations to clarify potential effects on v...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases Jg. 75; H. 3; S. 522 - 524
Hauptverfasser: Micheli, Valeria, Bracchitta, Fiorenza, Rizzo, Alberto, Mancon, Alessandro, Mileto, Davide, Lombardi, Alessandra, Stefanelli, Paola, Gismondo, Maria Rita
Format: Journal Article
Sprache:Englisch
Veröffentlicht: US Oxford University Press 31.08.2022
Schlagworte:
COVID-19
SARS-CoV-2
Omicron
B.1.1.529
viral variants
ISSN:1058-4838, 1537-6591, 1537-6591
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Abstract We identified the first case in Italy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 variant, using whole-genome sequencing in an Italian subject traveling from Mozambique. Specific mutation profiles deserve further investigations to clarify potential effects on vaccination efficacy. This case highlights the crucial role of rapid and continuous surveillance of SARS-CoV-2 variant circulation.
AbstractList We identified the first case in Italy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 variant, using whole-genome sequencing in an Italian subject traveling from Mozambique. Specific mutation profiles deserve further investigations to clarify potential effects on vaccination efficacy. This case highlights the crucial role of rapid and continuous surveillance of SARS-CoV-2 variant circulation.We identified the first case in Italy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 variant, using whole-genome sequencing in an Italian subject traveling from Mozambique. Specific mutation profiles deserve further investigations to clarify potential effects on vaccination efficacy. This case highlights the crucial role of rapid and continuous surveillance of SARS-CoV-2 variant circulation.
Abstract We identified the first case in Italy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 variant, using whole-genome sequencing in an Italian subject traveling from Mozambique. Specific mutation profiles deserve further investigations to clarify potential effects on vaccination efficacy. This case highlights the crucial role of rapid and continuous surveillance of SARS-CoV-2 variant circulation.
Author Mileto, Davide
Stefanelli, Paola
Micheli, Valeria
Rizzo, Alberto
Lombardi, Alessandra
Gismondo, Maria Rita
Mancon, Alessandro
Bracchitta, Fiorenza
Author_xml – sequence: 1
  givenname: Valeria
  orcidid: 0000-0001-5629-3875
  surname: Micheli
  fullname: Micheli, Valeria
  email: valeria.micheli@asst-fbf-sacco.it
– sequence: 2
  givenname: Fiorenza
  surname: Bracchitta
  fullname: Bracchitta, Fiorenza
– sequence: 3
  givenname: Alberto
  surname: Rizzo
  fullname: Rizzo, Alberto
– sequence: 4
  givenname: Alessandro
  surname: Mancon
  fullname: Mancon, Alessandro
– sequence: 5
  givenname: Davide
  surname: Mileto
  fullname: Mileto, Davide
– sequence: 6
  givenname: Alessandra
  surname: Lombardi
  fullname: Lombardi, Alessandra
– sequence: 7
  givenname: Paola
  surname: Stefanelli
  fullname: Stefanelli, Paola
– sequence: 8
  givenname: Maria Rita
  surname: Gismondo
  fullname: Gismondo, Maria Rita
BookMark eNo1kEtPwzAQhC1UJNrCjR_gG-WQ4kecx7FUFCpVVKLANXKcjTBK7GA7Rfn3BBU0Ws3sarSHb4YmxhpA6JqSJSU5v1O6GkeWlMTxGZpSwdMoETmdjJmILIoznl2gmfefhFCaETFFYaOdD3hbgQm61koGbQ22NQ4fgJ_hGx_gCA7wSvUB8Av4TjsZrBvwYTCVsy3gtXXWyKN2vccM71utxh2_S6elCXhxv6SjBMtvsTZ4G2QzXKLzWjYerv58jt42D6_rp2i3f9yuV7tIxSIPETDOZa5YzZMUMlKWeVxWMk5YRliZpkzUCeMUEqIE56nI5XgDkoBIS0lLCXyOFqe_nbNfPfhQtNoraBppwPa-YAljLMsEEWP15lS1fVd0TrfSDQUlxS_XYuRa_HPlP3bfbJE
CitedBy_id crossref_primary_10_1007_s10157_022_02283_0
crossref_primary_10_3390_pathogens11091058
crossref_primary_10_1016_j_jiph_2022_07_013
crossref_primary_10_1016_j_ijid_2024_107262
crossref_primary_10_1016_j_jiph_2022_11_024
crossref_primary_10_1016_j_envres_2022_113229
crossref_primary_10_1128_aac_01115_23
crossref_primary_10_3390_healthcare10122427
crossref_primary_10_3390_microorganisms10101954
crossref_primary_10_1080_22221751_2022_2045878
crossref_primary_10_3390_diagnostics12092245
ContentType Journal Article
Copyright The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. 2022
The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America.
Copyright_xml – notice: The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. 2022
– notice: The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America.
DBID TOX
7X8
DOI 10.1093/cid/ciab1044
DatabaseName Oxford Journals Open Access Collection
MEDLINE - Academic
DatabaseTitle MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Database_xml – sequence: 1
  dbid: TOX
  name: Oxford Journals Open Access Collection
  url: https://academic.oup.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1537-6591
EndPage 524
ExternalDocumentID 10.1093/cid/ciab1044
GroupedDBID ---
..I
.2P
.GJ
.I3
.ZR
08P
0R~
1KJ
1TH
29B
2AX
2WC
36B
3O-
4.4
48X
53G
5GY
5RE
5VS
5WD
6J9
70D
AABZA
AACGO
AACZT
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAYOK
ABBHK
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNGD
ABNHQ
ABNKS
ABOCM
ABPLY
ABPQP
ABPTD
ABQLI
ABQNK
ABSMQ
ABTLG
ABVGC
ABWST
ABXSQ
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACHIC
ACPQN
ACPRK
ACUFI
ACUKT
ACUTJ
ACUTO
ACVCV
ACYHN
ACZBC
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADMTO
ADNBA
ADOCK
ADQBN
ADQXQ
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKPW
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFNX
AFFQV
AFFZL
AFIYH
AFOFC
AFRAH
AFSHK
AFXAL
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AI.
AIAGR
AIJHB
AJDVS
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APJGH
APWMN
AQDSO
AQKUS
AQVQM
ASPBG
ATGXG
AVNTJ
AVWKF
AXUDD
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
BZKNY
C1A
C45
CDBKE
CS3
CZ4
DAKXR
DCCCD
DIK
DILTD
DU5
D~K
E3Z
EBS
EE~
EIHJH
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FEDTE
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
H13
H5~
HAR
HQ3
HTVGU
HVGLF
HW0
HZ~
IOX
IPSME
J21
J5H
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
JXSIZ
KAQDR
KBUDW
KOP
KSI
KSN
L7B
M49
MBLQV
MHKGH
MJL
ML0
N4W
N9A
NGC
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OBFPC
OCZFY
ODMLO
ODZKP
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
P6G
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TMA
TOX
TR2
VH1
W8F
X7H
Y6R
YAYTL
YKOAZ
YXANX
ZGI
~91
~S-
7X8
AHGBF
AJBYB
ID FETCH-LOGICAL-c459t-e233a9c2f367e80bb94bda462802b7725f6231e60c533759a772e06e57ba1bae3
IEDL.DBID TOX
ISICitedReferencesCount 13
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000757224300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1058-4838
1537-6591
IngestDate Thu Oct 02 05:42:36 EDT 2025
Wed Apr 02 07:03:47 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords COVID-19
SARS-CoV-2
Omicron
B.1.1.529
viral variants
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c459t-e233a9c2f367e80bb94bda462802b7725f6231e60c533759a772e06e57ba1bae3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-5629-3875
OpenAccessLink https://dx.doi.org/10.1093/cid/ciab1044
PQID 2622288505
PQPubID 23479
PageCount 3
ParticipantIDs proquest_miscellaneous_2622288505
oup_primary_10_1093_cid_ciab1044
PublicationCentury 2000
PublicationDate 2022-08-31
PublicationDateYYYYMMDD 2022-08-31
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-31
  day: 31
PublicationDecade 2020
PublicationPlace US
PublicationPlace_xml – name: US
PublicationTitle Clinical infectious diseases
PublicationYear 2022
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
SSID ssj0011805
Score 2.469256
Snippet Abstract We identified the first case in Italy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 variant, using whole-genome sequencing...
We identified the first case in Italy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 variant, using whole-genome sequencing in an...
SourceID proquest
oup
SourceType Aggregation Database
Publisher
StartPage 522
Title First Identification of the New Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant (B.1.1.529) in Italy
URI https://www.proquest.com/docview/2622288505
Volume 75
WOSCitedRecordID wos000757224300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS8NAEF60iHjxLdZHGcGDHqLJJpvsHmux6MFWbJXewu52Aj2YSpsW_PfOpqlCEZTcFhKW2cnsN_PNg7HLSJgwJqvnGV9aL8qi2NNGBJ7lvsyM0IYrXQ6bSDodORio56pJ0vQXCl-Ft5ZOhfZpyHFwfT8DIZ0-97uDb7YgkGWqIkGFMjgmqwT31ZdXatiWRre8Sdo7_97DLtuuwCI0F6e7x9Yw32ebTxUdfsCK9ojAGyyKbbMq-gbjDAjVAZkv6CFpKkLTzgqElx9WHXpVowJouQ4Gej6azKbAofvu8vNyeCMPmkQOV3c3AT2Cq2sY5fBISP3zkL227_utB68ao-DZSKjCQx6GWlmehXGC0jdGRWaoXU2qzw2Ba5ERBAow9i1Bv0QoTWvoxygSowOjMTxitXyc4zGDSPg6CLMhYpxESP--sYYgETkdCjPDh3UGJOH0Y9EoI10Q3GHqpgMvpVdnF0vxp6TJjp7QOY5n05THLholCZKd_P2ZU7bFXSFCGd09Y7ViMsNztmHnxWg6abD1ZCAbpZJ8AX-rtp8
linkProvider Oxford University Press
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=First+Identification+of+the+New+Severe+Acute+Respiratory+Syndrome+Coronavirus+2+Omicron+Variant+%28B.1.1.529%29+in+Italy&rft.jtitle=Clinical+infectious+diseases&rft.au=Micheli%2C+Valeria&rft.au=Bracchitta%2C+Fiorenza&rft.au=Rizzo%2C+Alberto&rft.au=Mancon%2C+Alessandro&rft.date=2022-08-31&rft.pub=Oxford+University+Press&rft.issn=1058-4838&rft.eissn=1537-6591&rft.volume=75&rft.issue=3&rft.spage=522&rft.epage=524&rft_id=info:doi/10.1093%2Fcid%2Fciab1044&rft.externalDocID=10.1093%2Fcid%2Fciab1044
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1058-4838&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1058-4838&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1058-4838&client=summon